Michael Michael

14PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsCancer geneticsPacific Peoples theory of change models for healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 24, 2026
Nivolumab and Ipilimumab Combination Treatment in Patients with Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer: Results from the Phase II MoST-CIRCUIT Trial.

|Jan 04, 2026
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study.

Michael Michael, Guy C Toner, Vinod Ganju

|Jun 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|May 27, 2025
Peptide receptor radionuclide therapy in malignant insulinoma.

David A Pattison, Grace Kong, Timothy Akhurst

|May 03, 2024
A systematic review and meta-analysis of the impacts of germline pharmacogenomics on severe toxicity and symptom burden in adult patients with cancer.

Senthil Lingaratnam, Mahek Shah, Joseph Nicolazzo

|Sep 15, 2023
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis.

Lisa Guccione, Karla Gough, Allison Drosdowsky

Pageof 3

Frequent Collaborators

3 joint publications

Jeanne Tie

3 joint publications

Karla Gough

3 joint publications

Nick Pavlakis

3 joint publications

David Wyld